Average Co-Inventor Count = 10.33
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Forma Therapeutics, Inc. (17 from 125 patents)
2. Forma Tm2, Inc. (4 from 4 patents)
3. Valo Health, Inc. (1 from 29 patents)
4. Valo Early Discovery, Inc. (1 from 15 patents)
5. Genosco (1 from 6 patents)
24 patents:
1. 12275715 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
2. 12064426 - Selective inhibitors of ROCK1 and ROCK2 protein kinases and uses thereof
3. 12018030 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
4. 11498913 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
5. 10934299 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
6. 10889567 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
7. 10807976 - Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
8. 10577329 - Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
9. 10550098 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
10. 10550099 - Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
11. 10414752 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
12. 10407419 - Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
13. 10377760 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
14. 10294206 - Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
15. 10280150 - Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors